Compare Carna Biosciences vs Solidus Biosciences
Customers evaluate the quality of Carna Biosciences's products using the following success metrics.
Overview
Carna Biosciences is 21 yrs old and is based in Japan.
Carna Biosciences is a clinical-stage biopharmaceutical company. It discovers and develops therapies to treat serious unmet medical needs, focusing on small-molecule drugs, mainly targeting protein kinases and epidermal growth factor (EGF) family molecules for their role in diseases such as cancer, inflammation, and dermatitis. It was founded in 2003 and is based in Kobe, Japan.
Solidus Biosciences is based in United States
Solidus Biosciences is a company focused on providing business intelligence in the pharmaceutical and biologic drugs sector. The company's main services include offering insights on life cycle management, brand erosion, generic entry, biosimilars, patents, sales, litigation, and more, all related to pharmaceutical and biologic drugs. The company primarily serves the biopharmaceutical industry. It is based in Troy, New York.
Demo Video
Investors
Mitsui & Co. Global Investment, JLabs
National Science Foundation, Rensselaer Polytechnic Institute
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Carna Biosciences has not claimed their profile.
Work for Carna Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Carna Biosciences?
Claim your profile now.
Information not available because Solidus Biosciences has not claimed their profile.
Work for Solidus Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Solidus Biosciences?
Claim your profile now.